Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.91 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.91 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.91 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.91 |
| ▸ | RELA | Q04206 | 1/20 | 0.91 |
| ▸ | MAOB | P27338 | 7/20 | 0.80 |
| ▸ | MAPT | P10636 | 5/20 | 0.80 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.80 |
| ▸ | MEN1 | O00255 | 2/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.80 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.80 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.80 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.80 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.80 |
| ▸ | F3 | P13726 | 2/20 | 0.77 |
| ▸ | XDH | P47989 | 2/20 | 0.73 |
| ▸ | MAOA | P21397 | 3/20 | 0.68 |
| ▸ | RAB9A | P51151 | 2/20 | 0.68 |
| ▸ | P4HB | P07237 | 1/20 | 0.68 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27977337 | 1.00 | BCHE (0.91) | BCHECYP3A4NFKB1NFKB2RELA | |
| 4-Methoxy Chalcone SCHEMBL521906 | 0.95 | BCHE (1.00) | BCHECYP3A4NFKB1NFKB2RELA | |
| 4-Methoxy Chalcone SCHEMBL1566431 | 0.95 | BCHE (1.00) | BCHECYP3A4NFKB1NFKB2RELA | |
| 4-Methoxy Chalcone SCHEMBL9338705 | 0.95 | BCHE (1.00) | BCHECYP3A4NFKB1NFKB2RELA | |
| SCHEMBL10017446 | 0.92 | BCHE (0.77) | BCHECYP3A4NFKB1NFKB2RELA | |
| 4'-Methoxychalcone SCHEMBL3698831 | 0.91 | MAOB (0.97) | BCHECYP3A4NFKB1NFKB2RELA | |
| 4'-Methoxychalcone SCHEMBL3698834 | 0.91 | MAOB (0.97) | BCHECYP3A4NFKB1NFKB2RELA | |
| SCHEMBL18972861 | 0.90 | BCHE (0.88) | BCHECYP3A4NFKB1NFKB2RELA | |
| 4'-Methoxychalcone SCHEMBL1675978 | 0.89 | MAOB (1.00) | BCHECYP3A4NFKB1NFKB2RELA | |
| 4'-Methoxychalcone SCHEMBL521905 | 0.89 | MAOB (1.00) | BCHECYP3A4NFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9523889-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-12-20 | — | — | US | disclosed |
| US-9507210-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9470929-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9465244-B2 | Liquid crystal display | SONY CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9366910-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-9235084-B2 | Liquid crystal display device and manufacturing method thereof | SONY CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9146425-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20150146148-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
| US-8993074-B2 | Liquid crystal display device and method of manufacturing the same | SONY CORPORATION (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20140307211-A1 | LIQUID CRYSTAL DISPLAY | SONY CORPORATION (JP) | 2014-10-16 | — | — | US | disclosed |
| US-8830428-B2 | Liquid crystal display element and liquid crystal display device | SONY CORPORATION (JP) | 2014-09-09 | — | — | US | disclosed |
| US-20140170926-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2014-06-19 | — | — | US | disclosed |
| US-20140111752-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2014-04-24 | — | — | US | disclosed |
| US-20130155360-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20130010244-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION | 2013-01-10 | — | — | US | disclosed |
| US-20120212691-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120026440-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20110273652-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110134382-A1 | LIQUID CRYSTAL DISPLAY ELEMENT AND LIQUID CRYSTAL DISPLAY DEVICE | SONY CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | PYM1, PDCD2L, SDAD1 | BCHE 3203/4885CYP3A4 2921/4885NFKB1 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.